June 18, 2019
The firm recently held its inaugural Healthcare and Life Sciences Summit in Boston, which was a half-day event that explored a broad range of sector issues occurring across the industry. Local leaders in pharma, medical device, and biotech discussed three key areas: Department of Justice enforcement priorities; Food and Drug Administration regulatory trends; and M&A market updates. The Summit also included a panel of in-house professionals at the end of the day who discussed and expanded on key issues keeping them up at night.
“The healthcare and life sciences space continues to evolve rapidly, and the industry footprint in our city of Boston just keeps growing,” said David Tolley, Boston partner. “The Summit served as a forum where we could bring together industry leaders on the front lines to exchange ideas, share knowledge, and plan for the future.”
Watch the recap video below to hear more about the event and what was discussed.